• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向药物递送系统用于消除细胞内细菌。

Targeted Drug Delivery Systems for Eliminating Intracellular Bacteria.

机构信息

State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.

AO Research Institute Davos, Davos, 7270, Switzerland.

出版信息

Macromol Biosci. 2023 Jan;23(1):e2200311. doi: 10.1002/mabi.202200311. Epub 2022 Oct 27.

DOI:10.1002/mabi.202200311
PMID:36189899
Abstract

The intracellular survival of pathogenic bacteria requires a range of survival strategies and virulence factors. These infections are a significant clinical challenge, wherein treatment frequently fails because of poor antibiotic penetration, stability, and retention in host cells. Drug delivery systems (DDSs) are promising tools to overcome these shortcomings and enhance the efficacy of antibiotic therapy. In this review, the classification and the mechanisms of intracellular bacterial persistence are elaborated. Furthermore, the systematic design strategies applied to DDSs to eliminate intracellular bacteria are also described, and the strategies used for internalization, intracellular activation, bacterial targeting, and immune enhancement are highlighted. Finally, this overview provides guidance for constructing functionalized DDSs to effectively eliminate intracellular bacteria.

摘要

胞内生存的病原菌需要一系列的生存策略和毒力因子。这些感染是一个重大的临床挑战,因为抗生素在宿主细胞中的穿透性差、稳定性差和保留性差,治疗常常失败。药物传递系统(DDS)是克服这些缺点和提高抗生素治疗效果的有前途的工具。在这篇综述中,阐述了胞内细菌持续存在的分类和机制。此外,还描述了系统设计策略在用于消除胞内细菌的 DDS 中的应用,并强调了用于内化、细胞内激活、细菌靶向和免疫增强的策略。最后,这篇综述为构建功能化的 DDS 以有效消除胞内细菌提供了指导。

相似文献

1
Targeted Drug Delivery Systems for Eliminating Intracellular Bacteria.靶向药物递送系统用于消除细胞内细菌。
Macromol Biosci. 2023 Jan;23(1):e2200311. doi: 10.1002/mabi.202200311. Epub 2022 Oct 27.
2
Cascade-Targeting Poly(amino acid) Nanoparticles Eliminate Intracellular Bacteria via On-Site Antibiotic Delivery.级联靶向聚(氨基酸)纳米颗粒通过现场递药消除细胞内细菌。
Adv Mater. 2022 Mar;34(12):e2109789. doi: 10.1002/adma.202109789. Epub 2022 Feb 13.
3
Recent Developments in Antibacterial Therapy: Focus on Stimuli-Responsive Drug-Delivery Systems and Therapeutic Nanoparticles.抗菌治疗的最新进展:聚焦刺激响应型药物传递系统和治疗性纳米颗粒。
Molecules. 2019 May 24;24(10):1991. doi: 10.3390/molecules24101991.
4
Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections.受生物启发的药物传递策略可用于重新利用常规抗生素来对抗细胞内感染。
Adv Drug Deliv Rev. 2021 Oct;177:113948. doi: 10.1016/j.addr.2021.113948. Epub 2021 Aug 28.
5
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.用于靶向刺激响应性药物递送的介孔二氧化硅纳米颗粒研究进展。
Expert Opin Drug Deliv. 2015 Feb;12(2):319-37. doi: 10.1517/17425247.2014.953051. Epub 2014 Nov 25.
6
Bacteria-Targeting Nanoparticles with Microenvironment-Responsive Antibiotic Release To Eliminate Intracellular Staphylococcus aureus and Associated Infection.细菌靶向纳米颗粒,具有微环境响应性抗生素释放,以消除细胞内金黄色葡萄球菌和相关感染。
ACS Appl Mater Interfaces. 2018 May 2;10(17):14299-14311. doi: 10.1021/acsami.7b15678. Epub 2018 Apr 19.
7
pH-Responsive Lipid-Dendrimer Hybrid Nanoparticles: An Approach To Target and Eliminate Intracellular Pathogens.pH 响应性脂质-树状聚合物杂化纳米颗粒:一种靶向和消除细胞内病原体的方法。
Mol Pharm. 2019 Nov 4;16(11):4594-4609. doi: 10.1021/acs.molpharmaceut.9b00713. Epub 2019 Oct 16.
8
Drug delivery systems for enhanced tumour treatment by eliminating intra-tumoral bacteria.用于消除肿瘤内细菌以增强肿瘤治疗效果的药物输送系统。
J Mater Chem B. 2024 Jan 31;12(5):1194-1207. doi: 10.1039/d3tb02362a.
9
Stimuli-responsive nanoplatforms for antibacterial applications.用于抗菌应用的刺激响应性纳米平台。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 May;14(3):e1775. doi: 10.1002/wnan.1775. Epub 2022 Feb 9.
10
Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections.抗生素纳米载体:治疗细胞内细菌感染的有前途的解决方案。
Int J Antimicrob Agents. 2014 Jun;43(6):485-96. doi: 10.1016/j.ijantimicag.2014.02.009. Epub 2014 Mar 22.

引用本文的文献

1
A Safe and Versatile Minicell Platform Derived from for Biotechnological Applications.一种源自用于生物技术应用的安全且通用的微细胞平台。 (你提供的原文“A Safe and Versatile Minicell Platform Derived from for Biotechnological Applications.”中“Derived from”后面似乎缺少内容)
J Microbiol Biotechnol. 2025 Sep 5;35:e2507031. doi: 10.4014/jmb.2503.07031.
2
Enhancing the therapeutical potential of metalloantibiotics using nano-based delivery systems.利用基于纳米的递送系统提高金属抗生素的治疗潜力。
Beilstein J Nanotechnol. 2025 Aug 15;16:1350-1366. doi: 10.3762/bjnano.16.98. eCollection 2025.
3
Supramolecular discrimination and diagnosis-guided treatment of intracellular bacteria.
细胞内细菌的超分子识别与诊断指导治疗
Nat Commun. 2025 Jan 25;16(1):1016. doi: 10.1038/s41467-025-56308-9.
4
Advance Progress in Assembly Mechanisms of Carrier-Free Nanodrugs for Cancer Treatment.载药型纳米药物递药系统的组装机制研究进展。
Molecules. 2023 Oct 13;28(20):7065. doi: 10.3390/molecules28207065.